Innovation in medicines
Submitted by Anonymous (not verified) on 23 January 2024 - 16:10
Innovation in medicines
Major update of the SME user guide
Submitted by Anonymous (not verified) on 23 January 2024 - 13:36
Major update of the SME user guide
Support to SMEs
Submitted by Anonymous (not verified) on 23 January 2024 - 13:35
Support to SMEs
Annex - National provisions for SMEs applicable to the pharmaceutical sector
Submitted by Anonymous (not verified) on 23 January 2024 - 13:34
Annex - National provisions for SMEs applicable to the pharmaceutical sector
User guide for micro, small and medium-sized enterprises
Submitted by Anonymous (not verified) on 23 January 2024 - 12:57
User guide for micro, small and medium-sized enterprises
Guideline on the clinical evaluation of anticancer medicinal products - Revision 6
Submitted by Anonymous (not verified) on 23 January 2024 - 12:37
Guideline on the clinical evaluation of anticancer medicinal products - Revision 6
Voxzogo
Submitted by Anonymous (not verified) on 23 January 2024 - 11:53
Voxzogo
Leqvio
Submitted by Anonymous (not verified) on 23 January 2024 - 11:47
Leqvio
Multi-stakeholder workshop on the guideline on clinical investigation of medicinal products in the treatment of epileptic disorders , Online, 29 January 2024
Submitted by Anonymous (not verified) on 22 January 2024 - 17:28
Multi-stakeholder workshop on the guideline on clinical investigation of medicinal products in the treatment of epileptic disorders , Online, 29 January 2024
Shortage of Rybelsus (semaglutide) supply shortage
Submitted by Anonymous (not verified) on 22 January 2024 - 16:18
Shortage of Rybelsus (semaglutide) supply shortage